Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here is the AMENDED PATENT showing the changes

<The recert published today states claims 1,6, 10,2,7,9 and new claims 11-16 are determined to be patentable, does this mean the original patents are or will be extended?>

I'm pretty sure the answer to the above question is no. It is the same patent. The new claims are not considered expanding/enlarging the scope of the original patent.

<Any new or amended claims are examined to ensure that the scope of the original patent claims is not enlarged, i.e., broadened. >

However, those new claims can make it easier for a court to determine infringement.

GLTA, Opty

Share
New Message
Please login to post a reply